ktsimage CSL (OTCPK:CSLLY) (OTCPK:CMXHF) has priced its one-time gene therapy Hemgenix for hemophilia B at $3.5M, making it the most…
ktsimage CSL (OTCPK:CSLLY) (OTCPK:CMXHF) has priced its one-time gene therapy Hemgenix for hemophilia B at $3.5M, making it the most…